187 related articles for article (PubMed ID: 10691197)
41. Mortality indicators in pneumococcal meningitis: therapeutic implications.
Erdem H; Elaldi N; Öztoprak N; Sengoz G; Ak O; Kaya S; Inan A; Nayman-Alpat S; Ulu-Kilic A; Pekok AU; Gunduz A; Gozel MG; Pehlivanoglu F; Yasar K; Yılmaz H; Hatipoglu M; Cicek-Senturk G; Akcam FZ; Inkaya AC; Kazak E; Sagmak-Tartar A; Tekin R; Ozturk-Engin D; Ersoy Y; Sipahi OR; Guven T; Tuncer-Ertem G; Alabay S; Akbulut A; Balkan II; Oncul O; Cetin B; Dayan S; Ersoz G; Karakas A; Ozgunes N; Sener A; Yesilkaya A; Erturk A; Gundes S; Karabay O; Sirmatel F; Tosun S; Turhan V; Yalci A; Akkoyunlu Y; Aydın E; Diktas H; Kose S; Ulcay A; Seyman D; Savasci U; Leblebicioglu H; Vahaboglu H
Int J Infect Dis; 2014 Feb; 19():13-9. PubMed ID: 24211227
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
París MM; Hickey SM; Trujillo M; Shelton S; McCracken GH
Antimicrob Agents Chemother; 1995 Jun; 39(6):1243-6. PubMed ID: 7574509
[TBL] [Abstract][Full Text] [Related]
43. [In vitro bactericide activity of different antibiotic combinations to Streptococcus pneumoniae resistant to penicillin and cefotaxime].
Tubau F; Liñares J; Ardanuy C; Martínez-Lacasa J; Fernández A; Cabellos C; Fernández-Viladrich P; Martín R
Enferm Infecc Microbiol Clin; 1996 Dec; 14(10):590-5. PubMed ID: 9053000
[TBL] [Abstract][Full Text] [Related]
44. Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
Lutsar I; Ahmed A; Friedland IR; Trujillo M; Wubbel L; Olsen K; McCracken GH
Antimicrob Agents Chemother; 1997 Nov; 41(11):2414-7. PubMed ID: 9371342
[TBL] [Abstract][Full Text] [Related]
45. Management of pneumococcal meningitis.
Kaplan SL
Pediatr Infect Dis J; 2002 Jun; 21(6):589-91; discussion 613-4. PubMed ID: 12182395
[TBL] [Abstract][Full Text] [Related]
46. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
Cormican MG; Erwin ME; Jones RN
Diagn Microbiol Infect Dis; 1995; 22(1-2):119-23. PubMed ID: 7587024
[TBL] [Abstract][Full Text] [Related]
47. Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
Antimicrob Agents Chemother; 2002 May; 46(5):1607-9. PubMed ID: 11959614
[TBL] [Abstract][Full Text] [Related]
48. Penicillin and ceftriaxone susceptibility of Streptococcus pneumoniae isolated from cerebrospinal fluid of children with meningitis hospitalized in a tertiary hospital in Israel.
Waisbourd-Zinman O; Bilavsky E; Tirosh N; Samra Z; Amir J
Isr Med Assoc J; 2010 Apr; 12(4):225-8. PubMed ID: 20803882
[TBL] [Abstract][Full Text] [Related]
49. Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
París MM; Hickey SM; Uscher MI; Shelton S; Olsen KD; McCracken GH
Antimicrob Agents Chemother; 1994 Jun; 38(6):1320-4. PubMed ID: 8092832
[TBL] [Abstract][Full Text] [Related]
50. Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sickle cell disease.
Chesney PJ; Davis Y; English BK; Wang WC
Pediatr Infect Dis J; 1995 Nov; 14(11):1013-5. PubMed ID: 8584345
[No Abstract] [Full Text] [Related]
51. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
Tan TQ; Schutze GE; Mason EO; Kaplan SL
Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
[TBL] [Abstract][Full Text] [Related]
52. Meningitis caused by Streptococcus pneumoniae showing high level resistance to penicillin.
Wise KA; Bedford M; Wadhwa SS; Slobodniuk R
Pathology; 1995 Apr; 27(2):165-7. PubMed ID: 7567146
[TBL] [Abstract][Full Text] [Related]
53. Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall.
Stucki A; Cottagnoud M; Winkelmann V; Schaffner T; Cottagnoud P
Antimicrob Agents Chemother; 2007 Jun; 51(6):2249-52. PubMed ID: 17371817
[TBL] [Abstract][Full Text] [Related]
54. Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitis.
Vivas M; Force E; Garrigós C; Tubau F; Platteel AC; Ariza J; Cabellos C
J Antimicrob Chemother; 2014 Nov; 69(11):3020-6. PubMed ID: 24962033
[TBL] [Abstract][Full Text] [Related]
55. Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae.
Bañón Arias R; García López M; Pinedo Sánchez A
J Chemother; 2001 Oct; 13(5):535-40. PubMed ID: 11760218
[TBL] [Abstract][Full Text] [Related]
56. Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae.
Friedland IR; Paris M; Shelton S; McCracken GH
J Antimicrob Chemother; 1994 Aug; 34(2):231-7. PubMed ID: 7814283
[TBL] [Abstract][Full Text] [Related]
57. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae.
Pikis A; Donkersloot JA; Akram S; Keith JM; Campos JM; Rodriguez WJ
J Antimicrob Chemother; 1997 Jul; 40(1):105-8. PubMed ID: 9249211
[TBL] [Abstract][Full Text] [Related]
58. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
Olivier C; Cohen R; Begué P; Floret D
Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
[No Abstract] [Full Text] [Related]
59. Combined treatment with ceftriaxone and linezolid of pneumococcal meningitis: a case series including penicillin-resistant strains.
Faella F; Pagliano P; Fusco U; Attanasio V; Conte M
Clin Microbiol Infect; 2006 Apr; 12(4):391-4. PubMed ID: 16524418
[TBL] [Abstract][Full Text] [Related]
60. Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile.
Fitoussi F; Doit C; Sandin A; Pechinot A; Kazmierczack A; Geslin P; Bingen E
Antimicrob Agents Chemother; 1995 Nov; 39(11):2560-3. PubMed ID: 8585745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
